In the News
Bloomberg ○ Suono Bio, Inc. Announces Oversubscribed Series A Funding Round Led by Axil Capital and Mizuho Securities Principal Investment
Business Wire ○ Suono Bio, Inc. Announces Oversubscribed Series A Funding Round Led by Axil Capital and Mizuho Securities Principal Investment
GEN Genetic Engineering & Biotechnology News ○ Genetic Engineering, No Virus Required
Forbes 30 Under 30 ○ Carl Schoellhammer is named a Forbes 30 Under 30 in Healthcare
Forbes ○ Carl Schoellhammer is profiled in Forbes
Fortune ○ Ultrasound May One Day Make the Drugs You Take More Effective
WIRED ○ The Second Coming of Ultrasound
Business Insider ○ Carl Schoellhammer named one of 30 biotech leaders under 40 shaping the future of medicine
Business Insider ○ Suono Bio announced as the first investment for MIT's Engine
Harvard Business Review ○ Profile of Professor Robert Langer and his keys to successful translation
MIT News and Engadget ○ RNA hitches a ride on ultrasound waves
National Collegiate Inventors Competition ○ Carl Schoellhammer wins the National Collegiate Inventors Competition for his work on the SuonoCalm
Bristol-Myers Squibb Golden Ticket Competition ○ Suono Bio was awarded a golden ticket for free laboratory space at LabCentral
OneStart Accelerator Competition ○ Suono Bio named 1 of 10 finalist teams out of almost 400 teams internationally
World Economic Forum Agenda ○ How can ultrasound improve drug delivery?
Popular Science ○ Ultrasound could deliver drugs more effectively to GI tract
U.S. News & World Report ○ Ultrasound might speed up digestive drug delivery
The Boston Globe ○ Device uses ultrasound to deliver drugs
Discovery News ○ Technology for ultra-rapid drug delivery invented
Entrepreneur ○ Suono Bio's technology is highlighted in Entrepreneur
MIT News ○ Using ultrasound to improve drug delivery
Beta Boston ○ Carl Schoellhammer wins the Lemelson-MIT National Student Prize for co-inventing ultrasound-mediated GI drug delivery
Business Wire ○ Suono Bio, Inc. Announces Oversubscribed Series A Funding Round Led by Axil Capital and Mizuho Securities Principal Investment
GEN Genetic Engineering & Biotechnology News ○ Genetic Engineering, No Virus Required
Forbes 30 Under 30 ○ Carl Schoellhammer is named a Forbes 30 Under 30 in Healthcare
Forbes ○ Carl Schoellhammer is profiled in Forbes
Fortune ○ Ultrasound May One Day Make the Drugs You Take More Effective
WIRED ○ The Second Coming of Ultrasound
Business Insider ○ Carl Schoellhammer named one of 30 biotech leaders under 40 shaping the future of medicine
Business Insider ○ Suono Bio announced as the first investment for MIT's Engine
Harvard Business Review ○ Profile of Professor Robert Langer and his keys to successful translation
MIT News and Engadget ○ RNA hitches a ride on ultrasound waves
National Collegiate Inventors Competition ○ Carl Schoellhammer wins the National Collegiate Inventors Competition for his work on the SuonoCalm
Bristol-Myers Squibb Golden Ticket Competition ○ Suono Bio was awarded a golden ticket for free laboratory space at LabCentral
OneStart Accelerator Competition ○ Suono Bio named 1 of 10 finalist teams out of almost 400 teams internationally
World Economic Forum Agenda ○ How can ultrasound improve drug delivery?
Popular Science ○ Ultrasound could deliver drugs more effectively to GI tract
U.S. News & World Report ○ Ultrasound might speed up digestive drug delivery
The Boston Globe ○ Device uses ultrasound to deliver drugs
Discovery News ○ Technology for ultra-rapid drug delivery invented
Entrepreneur ○ Suono Bio's technology is highlighted in Entrepreneur
MIT News ○ Using ultrasound to improve drug delivery
Beta Boston ○ Carl Schoellhammer wins the Lemelson-MIT National Student Prize for co-inventing ultrasound-mediated GI drug delivery
Press Releases
January 2022 ○ Suono Bio Announces Formulation-Agnostic Platform for the Delivery of RNA Therapeutics
December 2021 ○ Suono Bio, Inc. Announces Exclusive Patent License with MIT for Portfolio of Granted IP Covering Formulation-Independent Drug Delivery
September 2018 ○ Suono Bio Announces Strategic Investment by FUJIFILM Corporation
December 2021 ○ Suono Bio, Inc. Announces Exclusive Patent License with MIT for Portfolio of Granted IP Covering Formulation-Independent Drug Delivery
September 2018 ○ Suono Bio Announces Strategic Investment by FUJIFILM Corporation
